-
Hey,
@GGRheumdoc, it's your study, quoted above House. (Slide source:#ACR19#CPC) Link to the 2007 study from@UWRheum: https://www.ncbi.nlm.nih.gov/pubmed/?term=17295432 …pic.twitter.com/gSm1wnSuY6
-
#ACR19 “Ancestry-Specific Classical HLA Alleles Define Phenotypic Subsets in the African American Scleroderma Population.” Ayla Safran, NIAMS Scleroderma Genomics and Health Disparities Unit. ACR Abstract Session 6W023, 11:00 AM. https://go.usa.gov/xpTPr pic.twitter.com/HKW7O3wIrF
-
#ACR19 Want to enhance your research skills? Work side-by-side with leading scientists in a collaborative and enriching environment with state-of-the-art facilities. Check out the training programs NIAMS offers: https://go.usa.gov/xpTyx pic.twitter.com/bQs0M9JKiR
-
Drug-induced liver injury (DILI); consider potential for interactions of several factors. Good resource = http://livertox.nih.gov
#ACR19 pic.twitter.com/MU76exlQhx
-
Phase 3 COAST-X trial results presented at
#ACR19 show blocking IL-17A is a potential option for treating nr-axSpA. Read more about the IL-23–IL-17 pathway as a therapeutic target in#AxialSpondyloarthritis in our#Review by Sieper et al https://go.nature.com/36ZOsVl@DrPoddubnyy -
With a famous musician revealing that he has myositis, Lisa Christopher-Stine says that they hoping it will bring more awareness to the disease.
#ACR19 https://www.baltimoresun.com/health/bs-md-ci-peter-frampton-doctors-20190226-story.html … -
Immune checkpoint inhibitors are a hot topic again this year - 61 abstracts at
#ACR19! To read more on rheumatic immune-related adverse events from#cancer#immunotherapy see our Review by Calabrese et al: http://go.nature.com/2LN4VQT@LCalabreseDO@CCalabreseDO@cappelliMD -
Great resource for rheumatic medications and breastfeeding. https://www.ncbi.nlm.nih.gov/books/NBK501922/ …
#ACR19@RheumNow#pregnancy -
Important to note that SELECT-MONOTHERAPY does NOT show superiority of upadacitinib over MTX Trial was MTX non-responders. Not surprising that patients randomized to MTX did worse. Real trial would be MTX vs. UPA upfront
#ACR19@RheumNow https://www.ncbi.nlm.nih.gov/pubmed/31130260 pic.twitter.com/cwt9kOmNal
-
#Atlanta Ferris wheel at sunrise. Here’s the backstory on how it made its way here in case anyone at#ACR19 is curious. https://www.usatoday.com/story/dispatches/2013/07/17/new-atlanta-attraction-skyview-ferris-wheel/2525391/ …pic.twitter.com/zgIdslF7mV
-
Think different lesson at opening lecture
Dr. Hu won 2015 Ig Nobel Prize, a satiric prize awarded annually to celebrate unusual/trivial achievements in scientific research as “honor achievements that first make people laugh & then make them think” https://www.nytimes.com/2018/11/05/science/hu-robotics.html … #ACR19 pic.twitter.com/96MPXgk2oP
Prikaži ovu nit -
#vitaminD
check out dec 2019
Current opinión endocrinológy
https://jmp.sh/w4QMloj
@AbelNovoa@angelopezh@joaqmorera@javierpadillab@rafabravo@quequesierra@sociedadSEEN Por qué holick defiende la vitamina D ?

https://www.nytimes.com/2018/08/18/business/vitamin-d-michael-holick.html#click=https://t.co/K7FOrArjRN …
#ACR19 pic.twitter.com/yX0bWMe6MV
-
Dr S Manzi
#ACR19#acrbest@rheumnow : Is renal biopsy a thing of the past? IFN levels in tubular cells and keratinocytes distinguishes those who have lupus nephritis from those who don’thttps://www.nature.com/articles/s41590-019-0386-1 … -
#ACR19 Interesting post-hoc analysis of MRSS from SLSI (CYC vs PLBO) and SLSII (CYC vs MMF) in SSc-ILD Both better than PLBO, CYC looks better than MMF but not significantly different Supports recent recs re:skin disease (see flowchart)@RheumNow https://www.ncbi.nlm.nih.gov/pubmed/28544580 pic.twitter.com/IeaTJHM5nq
-
#ACR19 - AM session re:classification vs diagnostic criteria, referencing 2016 Sjogrens Guidelines 1. Designed for rsrch 2. May miss important cases (lower sensitivity) 3. Not intended for diagnosis Remember this when using them in practice!@RheumNow https://www.ncbi.nlm.nih.gov/pubmed/27789466 pic.twitter.com/xyOpkh9mSC
-
Reading
#ACR19 tweets thinking they should add an exclamation mark to the end of the ACR logo https://www.theatlantic.com/technology/archive/2018/06/exclamation-point-inflation/563774/ …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.